#rare disease
5 articles with this tag
Pharmaceutical & Biotech
Rare Disease Patient Journey Leadership: How CEOs Invest Time to Understand and Advocate
How CEOs of rare disease companies invest time understanding patient journeys and building advocacy that accelerates development and improves outcomes.
Pharmaceutical & Biotech
Time Management for mRNA Platform Biotech CEOs
mRNA platform biotech CEO time management: how leaders balance pipeline programs, manufacturing scale decisions.
Pharmaceutical & Biotech
Time Management for Pharma CEOs Managing Multiple Therapeutic Areas
How mid-size pharma CEOs managing pipelines across oncology, immunology, and rare disease manage time for scientific credibility, regulatory strategy.
Pharmaceutical & Biotech
Time Management for Pharma CEOs Managing Orphan Drug Designation
How pharma CEOs manage time for orphan drug designation strategy with FDA ODD and EMA ODD, market exclusivity for rare disease drugs.
Pharmaceutical & Biotech
Time Management for Rare Disease Pharma CEOs
Time management strategies for rare disease pharma CEOs managing patient advocacy, natural history studies, FDA Breakthrough designation.